Musiktherapie zur Schmerzbehandlung während einer Hernienoperation: Eine klinische Studie
This innovative clinical trial explores the potential of music therapy to reduce postoperative pain and narcotic use in patients undergoing hernia repair surgery. Conducted by TriHealth Inc., the study aims to determine whether listening to preferred music before and/or during surgery can positively impact pain perception and medication requirements.
Study Design: The research employs a rigorous randomized, double-blinded, controlled design with four distinct groups:
- Pre-operative music only
- Pre-operative and intra-operative music
- Intra-operative music only
- No music exposure (control group)
Primary Objectives: The trial will measure two key outcomes:
- The highest pain score reported postoperatively (using a 0-10 scale)
- The total amount of narcotic medication administered in recovery
Patient Selection: The study will enroll 308 adult patients (18+ years) undergoing hernia repair at Bethesda Surgery Center. Participants must be English-speaking and able to provide consent. Important exclusions include hearing impairments, pregnancy, multiple hernia repairs, and current treatment for substance use disorders.
Scientific Significance: This research addresses a notable gap in perioperative care literature. While music therapy has shown benefits in various medical contexts, its specific application for hernia surgery patients remains unexplored. The findings could lead to non-pharmacological pain management strategies that reduce opioid dependence while improving patient comfort.
Implementation: Participants in the music groups will listen to their preferred genre through headphones during designated periods. The triple-blind design ensures objectivity by preventing patients, clinicians, and outcome assessors from knowing group assignments.
With an estimated completion date of August 2026, this study may significantly influence postoperative care protocols for hernia surgeries and potentially other surgical procedures.
Lesen Sie die vollständige Beschreibung der Studie:
Bevorstehende klinische Studien
-
NCT07948928RekrutierungDiabetes mellitus, Typ 2 | Diabetes Mellitus
-
NCT07937228Rekrutierung
-
NCT07882173Noch keine Rekrutierung
-
NCT07902921Noch keine RekrutierungNicht-kleinzelligem Lungenkrebs | NSCLC | Lungenkrebs | Prostatakrebs | mCRPC | Metastasierter kastrationsresistenter Prostatakrebs | Thymusepitheltumoren | TETs | Thymic Carcinomas | Thymomas
-
NCT07882160RekrutierungFettsäuren, Omega-3 | Fischöle
-
NCT07853781Rekrutierung
-
NCT07859800Noch keine Rekrutierung
-
NCT07828613Noch keine RekrutierungOffene Tibiafraktur | Extremitätenfraktur unten | Offene Knöchelluxation | Extremitätenverletzungen geringer
-
NCT07796373Noch keine RekrutierungChronischer lymphatischer Leukämie | Kleine lymphatische Leukämie
-
NCT07764536RekrutierungAufmerksamkeits-Defizit-Hyperaktivitäts-Störung | Verhaltensstörung | Oppositionelles Trotzverhalten | Störende Verhaltensstörungen
-
NCT07756840Noch keine RekrutierungKehlkopferkrankungen | Trachealerkrankungen | Humanes Papillomavirus (HPV) | Papillomavirus-Infektion | Neoplasma der Atemwege | Respiratory Recurrent Papillomatosis (RRP)